Circ‐AKT3 inhibits the accumulation of extracellular matrix of mesangial cells in diabetic nephropathy via modulating miR‐296‐3p/E‐cadherin signals
Diabetic nephropathy is a leading cause of end‐stage renal disease globally. The vital role of circular RNAs (circRNAs) has been reported in diabetic nephropathy progression, but the molecular mechanism linking diabetic nephropathy to circRNAs remains elusive. In this study, we investigated the sign...
Saved in:
Published in | Journal of cellular and molecular medicine Vol. 24; no. 15; pp. 8779 - 8788 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
John Wiley & Sons, Inc
01.08.2020
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Diabetic nephropathy is a leading cause of end‐stage renal disease globally. The vital role of circular RNAs (circRNAs) has been reported in diabetic nephropathy progression, but the molecular mechanism linking diabetic nephropathy to circRNAs remains elusive. In this study, we investigated the significant function of circ‐AKT3/miR‐296‐3p/E‐cadherin regulatory network on the extracellular matrix accumulation in mesangial cells in diabetic nephropathy. The expression of circ‐AKT3 and fibrosis‐associated proteins, including fibronectin, collagen type I and collagen type IV, was assessed via RT‐PCR and Western blot analysis in diabetic nephropathy animal model and mouse mesangial SV40‐MES13 cells. Luciferase reporter assays were used to investigate interactions among E‐cadherin, circ‐AKT3 and miR‐296‐3p in mouse mesangial SV40‐MES13 cells. Cell apoptosis was evaluated via flow cytometry. The level of circ‐AKT3 was significantly lower in diabetic nephropathy mice model group and mouse mesangial SV40‐MES13 cells treated with high‐concentration (25 mmol/L) glucose. In addition, circ‐AKT3 overexpression inhibited the level of fibrosis‐associated protein, such as fibronectin, collagen type I and collagen type IV. Circ‐AKT3 overexpression also inhibited the apoptosis of mouse mesangial SV40‐MES13 cells treated with high glucose. Luciferase reporter assay and bioinformatics tools identified that circ‐AKT3 could act as a sponge of miR‐296‐3p and E‐cadherin was the miR‐296‐3p direct target. Moreover, circ‐AKT3/miR‐296‐3p/E‐cadherin modulated the extracellular matrix of mouse mesangial cells in high‐concentration (25 mmol/L) glucose, inhibiting the synthesis of related extracellular matrix protein. In conclusion, circ‐AKT3 inhibited the extracellular matrix accumulation in diabetic nephropathy mesangial cells through modulating miR‐296‐3p/E‐cadherin signals, which might offer novel potential opportunities for clinical diagnosis targets and therapeutic biomarkers for diabetic nephropathy. |
---|---|
AbstractList | Diabetic nephropathy is a leading cause of end-stage renal disease globally. The vital role of circular RNAs (circRNAs) has been reported in diabetic nephropathy progression, but the molecular mechanism linking diabetic nephropathy to circRNAs remains elusive. In this study, we investigated the significant function of circ-AKT3/miR-296-3p/E-cadherin regulatory network on the extracellular matrix accumulation in mesangial cells in diabetic nephropathy. The expression of circ-AKT3 and fibrosis-associated proteins, including fibronectin, collagen type I and collagen type IV, was assessed via RT-PCR and Western blot analysis in diabetic nephropathy animal model and mouse mesangial SV40-MES13 cells. Luciferase reporter assays were used to investigate interactions among E-cadherin, circ-AKT3 and miR-296-3p in mouse mesangial SV40-MES13 cells. Cell apoptosis was evaluated via flow cytometry. The level of circ-AKT3 was significantly lower in diabetic nephropathy mice model group and mouse mesangial SV40-MES13 cells treated with high-concentration (25 mmol/L) glucose. In addition, circ-AKT3 overexpression inhibited the level of fibrosis-associated protein, such as fibronectin, collagen type I and collagen type IV. Circ-AKT3 overexpression also inhibited the apoptosis of mouse mesangial SV40-MES13 cells treated with high glucose. Luciferase reporter assay and bioinformatics tools identified that circ-AKT3 could act as a sponge of miR-296-3p and E-cadherin was the miR-296-3p direct target. Moreover, circ-AKT3/miR-296-3p/E-cadherin modulated the extracellular matrix of mouse mesangial cells in high-concentration (25 mmol/L) glucose, inhibiting the synthesis of related extracellular matrix protein. In conclusion, circ-AKT3 inhibited the extracellular matrix accumulation in diabetic nephropathy mesangial cells through modulating miR-296-3p/E-cadherin signals, which might offer novel potential opportunities for clinical diagnosis targets and therapeutic biomarkers for diabetic nephropathy.Diabetic nephropathy is a leading cause of end-stage renal disease globally. The vital role of circular RNAs (circRNAs) has been reported in diabetic nephropathy progression, but the molecular mechanism linking diabetic nephropathy to circRNAs remains elusive. In this study, we investigated the significant function of circ-AKT3/miR-296-3p/E-cadherin regulatory network on the extracellular matrix accumulation in mesangial cells in diabetic nephropathy. The expression of circ-AKT3 and fibrosis-associated proteins, including fibronectin, collagen type I and collagen type IV, was assessed via RT-PCR and Western blot analysis in diabetic nephropathy animal model and mouse mesangial SV40-MES13 cells. Luciferase reporter assays were used to investigate interactions among E-cadherin, circ-AKT3 and miR-296-3p in mouse mesangial SV40-MES13 cells. Cell apoptosis was evaluated via flow cytometry. The level of circ-AKT3 was significantly lower in diabetic nephropathy mice model group and mouse mesangial SV40-MES13 cells treated with high-concentration (25 mmol/L) glucose. In addition, circ-AKT3 overexpression inhibited the level of fibrosis-associated protein, such as fibronectin, collagen type I and collagen type IV. Circ-AKT3 overexpression also inhibited the apoptosis of mouse mesangial SV40-MES13 cells treated with high glucose. Luciferase reporter assay and bioinformatics tools identified that circ-AKT3 could act as a sponge of miR-296-3p and E-cadherin was the miR-296-3p direct target. Moreover, circ-AKT3/miR-296-3p/E-cadherin modulated the extracellular matrix of mouse mesangial cells in high-concentration (25 mmol/L) glucose, inhibiting the synthesis of related extracellular matrix protein. In conclusion, circ-AKT3 inhibited the extracellular matrix accumulation in diabetic nephropathy mesangial cells through modulating miR-296-3p/E-cadherin signals, which might offer novel potential opportunities for clinical diagnosis targets and therapeutic biomarkers for diabetic nephropathy. Diabetic nephropathy is a leading cause of end‐stage renal disease globally. The vital role of circular RNAs (circRNAs) has been reported in diabetic nephropathy progression, but the molecular mechanism linking diabetic nephropathy to circRNAs remains elusive. In this study, we investigated the significant function of circ‐AKT3/miR‐296‐3p/E‐cadherin regulatory network on the extracellular matrix accumulation in mesangial cells in diabetic nephropathy. The expression of circ‐AKT3 and fibrosis‐associated proteins, including fibronectin, collagen type I and collagen type IV, was assessed via RT‐PCR and Western blot analysis in diabetic nephropathy animal model and mouse mesangial SV40‐MES13 cells. Luciferase reporter assays were used to investigate interactions among E‐cadherin, circ‐AKT3 and miR‐296‐3p in mouse mesangial SV40‐MES13 cells. Cell apoptosis was evaluated via flow cytometry. The level of circ‐AKT3 was significantly lower in diabetic nephropathy mice model group and mouse mesangial SV40‐MES13 cells treated with high‐concentration (25 mmol/L) glucose. In addition, circ‐AKT3 overexpression inhibited the level of fibrosis‐associated protein, such as fibronectin, collagen type I and collagen type IV. Circ‐AKT3 overexpression also inhibited the apoptosis of mouse mesangial SV40‐MES13 cells treated with high glucose. Luciferase reporter assay and bioinformatics tools identified that circ‐AKT3 could act as a sponge of miR‐296‐3p and E‐cadherin was the miR‐296‐3p direct target. Moreover, circ‐AKT3/miR‐296‐3p/E‐cadherin modulated the extracellular matrix of mouse mesangial cells in high‐concentration (25 mmol/L) glucose, inhibiting the synthesis of related extracellular matrix protein. In conclusion, circ‐AKT3 inhibited the extracellular matrix accumulation in diabetic nephropathy mesangial cells through modulating miR‐296‐3p/E‐cadherin signals, which might offer novel potential opportunities for clinical diagnosis targets and therapeutic biomarkers for diabetic nephropathy. Diabetic nephropathy is a leading cause of end-stage renal disease globally. The vital role of circular RNAs (circRNAs) has been reported in diabetic nephropathy progression, but the molecular mechanism linking diabetic nephropathy to circRNAs remains elusive. In this study, we investigated the significant function of circ-AKT3/miR-296-3p/E-cadherin regulatory network on the extracellular matrix accumulation in mesangial cells in diabetic nephropathy. The expression of circ-AKT3 and fibrosis-associated proteins, including fibronectin, collagen type I and collagen type IV, was assessed via RT-PCR and Western blot analysis in diabetic nephropathy animal model and mouse mesangial SV40-MES13 cells. Luciferase reporter assays were used to investigate interactions among E-cadherin, circ-AKT3 and miR-296-3p in mouse mesangial SV40-MES13 cells. Cell apoptosis was evaluated via flow cytometry. The level of circ-AKT3 was significantly lower in diabetic nephropathy mice model group and mouse mesangial SV40-MES13 cells treated with high-concentration (25 mmol/L) glucose. In addition, circ-AKT3 overexpression inhibited the level of fibrosis-associated protein, such as fibronectin, collagen type I and collagen type IV. Circ-AKT3 overexpression also inhibited the apoptosis of mouse mesangial SV40-MES13 cells treated with high glucose. Luciferase reporter assay and bioinformatics tools identified that circ-AKT3 could act as a sponge of miR-296-3p and E-cadherin was the miR-296-3p direct target. Moreover, circ-AKT3/miR-296-3p/E-cadherin modulated the extracellular matrix of mouse mesangial cells in high-concentration (25 mmol/L) glucose, inhibiting the synthesis of related extracellular matrix protein. In conclusion, circ-AKT3 inhibited the extracellular matrix accumulation in diabetic nephropathy mesangial cells through modulating miR-296-3p/E-cadherin signals, which might offer novel potential opportunities for clinical diagnosis targets and therapeutic biomarkers for diabetic nephropathy. |
Author | Li, Weiliang Tang, Bo Bai, Shoujun Li, Xiao‐Ying Qu, Xiaolei Feng, Linhong Ji, Ting‐Ting |
AuthorAffiliation | 1 Department of Nephrology Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University Shanghai China |
AuthorAffiliation_xml | – name: 1 Department of Nephrology Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University Shanghai China |
Author_xml | – sequence: 1 givenname: Bo surname: Tang fullname: Tang, Bo organization: Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University – sequence: 2 givenname: Weiliang surname: Li fullname: Li, Weiliang organization: Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University – sequence: 3 givenname: Ting‐Ting surname: Ji fullname: Ji, Ting‐Ting organization: Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University – sequence: 4 givenname: Xiao‐Ying surname: Li fullname: Li, Xiao‐Ying organization: Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University – sequence: 5 givenname: Xiaolei surname: Qu fullname: Qu, Xiaolei organization: Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University – sequence: 6 givenname: Linhong surname: Feng fullname: Feng, Linhong organization: Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University – sequence: 7 givenname: Shoujun orcidid: 0000-0002-6100-2558 surname: Bai fullname: Bai, Shoujun email: shoujunbai2011@163.com organization: Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32597022$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ksluFDEQhlsoiCxw4QGQJS5RpEm89GJfkKJRWBMhoXC23O7qaY_a9mB3h8wtj8Cdt-NJcM9MEEQoPris8ld_Vdl1mO057yDLXhJ8StI6W2prT0lREPYkOyAFp7NcsHxvdyac8f3sMMYlxqwkTDzL9hktRIUpPch-zk3Qv-5-nH-6Zsi4ztRmiGjoACmtRzv2ajDeId8iuB2C0tD3yReQVUMwt5PfQlRuYVSPpsuYRFBjVA2D0cjBqgt-pYZujW6MQtY3G0W3QNZ8SWmpKNPOVmcXyWjVdBBSfDQLp_r4PHvaJgMvdvYo-_r24nr-fnb5-d2H-fnlTOdVyWZtSyqCFac1LgEYoW3dCsYrJlhVAW-EYpyRqhRlmxPe4AYwhSpXtFB5KwpgR9mbre5qrC00GlzqtJerYKwKa-mVkf_eONPJhb-RVU5oznASON4JBP9thDhIa-L0GsqBH6OkKW-VWuUT-voBuvRjmLpNVMlzxrGgj1MMi5xRPlGv_q77T8H3v5sAvAV08DEGaKU2w-ZDUxumlwTLaYDkNEByM0Ap5ORByL3qf2Gyhb-bHtaPkPLj_OpqG_MbsvPa3Q |
CitedBy_id | crossref_primary_10_3389_fphar_2021_615882 crossref_primary_10_1038_s41419_022_04612_3 crossref_primary_10_3389_fgene_2022_1062293 crossref_primary_10_1016_j_fct_2021_112074 crossref_primary_10_1007_s11010_022_04420_5 crossref_primary_10_3389_fendo_2023_1133970 crossref_primary_10_1007_s10528_024_10694_9 crossref_primary_10_1111_nep_14112 crossref_primary_10_1159_000516870 crossref_primary_10_3389_fmed_2021_714958 crossref_primary_10_1080_13813455_2023_2212328 crossref_primary_10_1089_ars_2021_0063 crossref_primary_10_1007_s10863_024_10027_w crossref_primary_10_1097_SHK_0000000000002389 crossref_primary_10_1007_s00592_022_01961_5 crossref_primary_10_1186_s13098_025_01593_z crossref_primary_10_1111_acel_14443 crossref_primary_10_14336_AD_2022_0203 crossref_primary_10_1007_s10753_022_01649_6 crossref_primary_10_3390_ijms251810051 crossref_primary_10_32604_biocell_2023_027373 crossref_primary_10_1155_2022_6103086 crossref_primary_10_1016_j_ymthe_2022_12_005 crossref_primary_10_1016_j_prp_2021_153618 crossref_primary_10_3389_fendo_2022_885650 crossref_primary_10_1111_jdi_14107 crossref_primary_10_3389_fgene_2022_1006307 crossref_primary_10_1016_j_biopha_2023_115818 crossref_primary_10_1002_mco2_699 crossref_primary_10_1016_j_arr_2021_101390 crossref_primary_10_1080_13510002_2024_2404794 crossref_primary_10_2174_0109298673271547231108060805 crossref_primary_10_3892_ijmm_2024_5368 |
Cites_doi | 10.1002/dmrr.2568 10.1016/j.drudis.2020.01.008 10.1155/2017/7805058 10.7150/thno.29678 10.1016/j.jfma.2018.02.007 10.1038/s41576-019-0158-7 10.18632/oncotarget.20205 10.1007/s10157-019-01744-3 10.1016/j.pharmthera.2018.01.010 10.1016/j.sjbs.2016.05.009 10.1186/s12967-018-1593-5 10.3390/genes8120353 10.1016/j.mce.2018.06.005 10.1681/ASN.2010020134 10.1002/jcp.29329 10.1007/s00125-012-2804-x 10.1002/wrna.1294 10.1038/nrneph.2017.31 10.1002/jcp.26895 10.1007/s10557-017-6755-9 10.1002/jcp.26959 10.1186/s12943-019-1072-5 |
ContentType | Journal Article |
Copyright | 2020 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2020 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd – notice: 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. – notice: 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7TK 7X7 7XB 88E 88I 8AO 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI Q9U RC3 PRINS 7X8 5PM |
DOI | 10.1111/jcmm.15513 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Journals ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Database ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection ProQuest Medical Database Science Database Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic Genetics Abstracts ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) ProQuest Central China MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database Publicly Available Content Database CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | TANG et al |
EISSN | 1582-4934 |
EndPage | 8788 |
ExternalDocumentID | PMC7412430 32597022 10_1111_jcmm_15513 JCMM15513 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Shanghai Municipal Commission of Health and Family Planning funderid: 201840254 – fundername: Shanghai Municipal Commission of Health and Family Planning grantid: 201840254 |
GroupedDBID | --- 0R~ 1OC 24P 29K 31~ 36B 3V. 4.4 53G 5GY 5VS 7X7 8-0 8-1 88E 88I 8AO 8FE 8FH 8FI 8FJ 8R4 8R5 AAHHS AAZKR ABUWG ACCFJ ACCMX ACGFS ACGOD ACXQS ADBBV ADKYN ADPDF ADRAZ ADZMN ADZOD AEEZP AENEX AEQDE AFBPY AFKRA AFZJQ AHMBA AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AOIJS AVUZU AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CAG CCPQU COF CS3 D-9 D-I DIK DU5 DWQXO E3Z EBD EBS EJD EMB EMOBN F5P FYUFA GNUQQ GODZA GROUPED_DOAJ HCIFZ HMCUK HYE HZ~ IAO IHR ITC KQ8 LH4 LK8 LW6 M1P M2P M48 M7P O9- OIG OK1 OVD OVEED PIMPY PQQKQ PROAC PSQYO Q2X RNS ROL RPM SV3 TEORI UKHRP WIN AAYXX ABJNI CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7QP 7TK 7XB 8FD 8FK AAMMB AEFGJ AGXDD AIDQK AIDYY FR3 K9. P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PUEGO Q9U RC3 PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c4763-ff1710a82b06ee312fbf938739377e8d9a38317696f418d0de02e74a25a4f95e3 |
IEDL.DBID | M48 |
ISSN | 1582-1838 1582-4934 |
IngestDate | Thu Aug 21 18:28:36 EDT 2025 Fri Jul 11 07:03:24 EDT 2025 Wed Aug 13 08:47:49 EDT 2025 Sat Aug 23 12:54:16 EDT 2025 Thu Apr 03 06:57:23 EDT 2025 Tue Jul 01 01:35:09 EDT 2025 Thu Apr 24 22:51:43 EDT 2025 Wed Jan 22 16:32:38 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 15 |
Keywords | miR-296-3p E-cadherin circ-AKT3 diabetic nephropathy |
Language | English |
License | Attribution 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4763-ff1710a82b06ee312fbf938739377e8d9a38317696f418d0de02e74a25a4f95e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-6100-2558 |
OpenAccessLink | https://www.proquest.com/docview/2430943282?pq-origsite=%requestingapplication% |
PMID | 32597022 |
PQID | 2430943282 |
PQPubID | 2034150 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7412430 proquest_miscellaneous_2418729680 proquest_journals_2468438092 proquest_journals_2430943282 pubmed_primary_32597022 crossref_citationtrail_10_1111_jcmm_15513 crossref_primary_10_1111_jcmm_15513 wiley_primary_10_1111_jcmm_15513_JCMM15513 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | August 2020 |
PublicationDateYYYYMMDD | 2020-08-01 |
PublicationDate_xml | – month: 08 year: 2020 text: August 2020 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Chichester – name: Hoboken |
PublicationTitle | Journal of cellular and molecular medicine |
PublicationTitleAlternate | J Cell Mol Med |
PublicationYear | 2020 |
Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc |
Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc |
References | 2017; 31 2010; 21 2017; 8 2019; 9 2018; 187 2015; 6 2018; 117 2019; 20 2017; 2017 2013; 56 2020 2015; 31 2018; 234 2019; 23 2017; 13 2017; 24 2018; 477 2019; 234 2019; 235 2019; 18 2018; 16 e_1_2_9_20_1 e_1_2_9_11_1 e_1_2_9_22_1 e_1_2_9_10_1 e_1_2_9_21_1 e_1_2_9_13_1 e_1_2_9_12_1 e_1_2_9_23_1 e_1_2_9_8_1 e_1_2_9_7_1 e_1_2_9_6_1 e_1_2_9_5_1 e_1_2_9_4_1 e_1_2_9_3_1 e_1_2_9_2_1 e_1_2_9_9_1 e_1_2_9_15_1 e_1_2_9_14_1 e_1_2_9_17_1 e_1_2_9_16_1 e_1_2_9_19_1 e_1_2_9_18_1 |
References_xml | – volume: 13 start-page: 311 year: 2017 end-page: 318 article-title: The role of the complement system in diabetic nephropathy publication-title: Nat Rev Nephrol – volume: 31 start-page: 221 year: 2015 end-page: 233 article-title: Research progress in signalling pathway in diabetic nephropathy publication-title: Diabetes Metab Res Rev – year: 2020 article-title: Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities publication-title: Drug Discov Today – volume: 6 start-page: 563 year: 2015 end-page: 579 article-title: Biogenesis, identification, and function of exonic circular RNAs publication-title: Wiley Interdiscip Rev RNA – volume: 18 start-page: 151 year: 2019 article-title: Circ‐AKT3 inhibits clear cell renal cell carcinoma metastasis via altering miR‐296‐3p/E‐cadherin signals publication-title: Mol Cancer – volume: 235 start-page: 4520 issue: 5 year: 2019 end-page: 4529 article-title: Circ_0080425 inhibits cell proliferation and fibrosis in diabetic nephropathy via sponging miR‐24‐3p and targeting fibroblast growth factor 11 publication-title: J Cell Physiol – volume: 23 start-page: 1050 year: 2019 end-page: 1057 article-title: E‐cadherin and periostin in early detection and progression of diabetic nephropathy: epithelial‐to‐mesenchymal transition publication-title: Clin Exp Nephrol – volume: 2017 start-page: 7805058 year: 2017 article-title: Epigenetic regulations in diabetic nephropathy publication-title: J Diabetes Res – volume: 477 start-page: 90 year: 2018 end-page: 102 article-title: MicroRNAs and diabetic kidney disease: systematic review and bioinformatic analysis publication-title: Mol Cell Endocrinol – volume: 234 start-page: 42 year: 2018 end-page: 50 article-title: The effects of expression of different microRNAs on insulin secretion and diabetic nephropathy progression publication-title: J Cell Physiol – volume: 234 start-page: 1469 year: 2019 end-page: 1476 article-title: Circular RNA circRNA_15698 aggravates the extracellular matrix of diabetic nephropathy mesangial cells via miR‐185/TGF‐β1 publication-title: J Cell Physiol – volume: 117 start-page: 662 year: 2018 end-page: 675 article-title: Update of pathophysiology and management of diabetic kidney disease publication-title: J Formos Med Assoc – volume: 20 start-page: 675 year: 2019 end-page: 691 article-title: The biogenesis, biology and characterization of circular RNAs publication-title: Nat Rev Genet – volume: 31 start-page: 579 year: 2017 end-page: 592 article-title: Diabetic Nephropathy: a Tangled Web to Unweave publication-title: Cardiovasc Drugs Ther – volume: 56 start-page: 663 year: 2013 end-page: 674 article-title: miR‐21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes publication-title: Diabetologia – volume: 21 start-page: 1317 year: 2010 end-page: 1325 article-title: miR‐192 mediates TGF‐beta/Smad3‐driven renal fibrosis publication-title: J Am Soc Nephrol – volume: 9 start-page: 588 year: 2019 end-page: 607 article-title: Circular RNAs in immune responses and immune diseases publication-title: Theranostics – volume: 187 start-page: 31 year: 2018 end-page: 44 article-title: Circular RNA and its mechanisms in disease: From the bench to the clinic publication-title: Pharmacol Ther – volume: 24 start-page: 843 year: 2017 end-page: 850 article-title: Changes in the NFκB and E‐cadherin expression are associated to diabetic nephropathy in publication-title: Saudi J Biol Sci – volume: 8 start-page: 78660 year: 2017 end-page: 78676 article-title: Sphingosine kinase 1 mediates AGEs‐induced fibronectin upregulation in diabetic nephropathy publication-title: Oncotarget – volume: 16 start-page: 220 year: 2018 article-title: A circRNA‐miRNA‐mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma publication-title: J Transl Med – volume: 8 start-page: 353 year: 2017 article-title: Circular RNAs (circRNAs) in Health and Disease publication-title: Genes (Basel) – ident: e_1_2_9_5_1 doi: 10.1002/dmrr.2568 – ident: e_1_2_9_20_1 doi: 10.1016/j.drudis.2020.01.008 – ident: e_1_2_9_15_1 doi: 10.1155/2017/7805058 – ident: e_1_2_9_8_1 doi: 10.7150/thno.29678 – ident: e_1_2_9_3_1 doi: 10.1016/j.jfma.2018.02.007 – ident: e_1_2_9_9_1 doi: 10.1038/s41576-019-0158-7 – ident: e_1_2_9_6_1 doi: 10.18632/oncotarget.20205 – ident: e_1_2_9_23_1 doi: 10.1007/s10157-019-01744-3 – ident: e_1_2_9_21_1 doi: 10.1016/j.pharmthera.2018.01.010 – ident: e_1_2_9_22_1 doi: 10.1016/j.sjbs.2016.05.009 – ident: e_1_2_9_11_1 doi: 10.1186/s12967-018-1593-5 – ident: e_1_2_9_10_1 doi: 10.3390/genes8120353 – ident: e_1_2_9_14_1 doi: 10.1016/j.mce.2018.06.005 – ident: e_1_2_9_17_1 doi: 10.1681/ASN.2010020134 – ident: e_1_2_9_12_1 doi: 10.1002/jcp.29329 – ident: e_1_2_9_16_1 doi: 10.1007/s00125-012-2804-x – ident: e_1_2_9_7_1 doi: 10.1002/wrna.1294 – ident: e_1_2_9_4_1 doi: 10.1038/nrneph.2017.31 – ident: e_1_2_9_18_1 doi: 10.1002/jcp.26895 – ident: e_1_2_9_2_1 doi: 10.1007/s10557-017-6755-9 – ident: e_1_2_9_19_1 doi: 10.1002/jcp.26959 – ident: e_1_2_9_13_1 doi: 10.1186/s12943-019-1072-5 |
SSID | ssj0036139 |
Score | 2.4684815 |
Snippet | Diabetic nephropathy is a leading cause of end‐stage renal disease globally. The vital role of circular RNAs (circRNAs) has been reported in diabetic... Diabetic nephropathy is a leading cause of end-stage renal disease globally. The vital role of circular RNAs (circRNAs) has been reported in diabetic... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 8779 |
SubjectTerms | Animal models Animals Antibodies Apoptosis Apoptosis - genetics Bioinformatics Cadherins - genetics circ‐AKT3 Collagen (type I) Collagen (type IV) Diabetes Diabetes mellitus Diabetic Nephropathies - etiology Diabetic Nephropathies - metabolism Diabetic Nephropathies - pathology Diabetic nephropathy Disease Disease Progression Disease Susceptibility Extracellular matrix Extracellular Matrix - metabolism E‐cadherin Fibronectin Fibrosis Flow cytometry Gene expression Gene Expression Regulation Genes, Reporter Glucose Kidneys Laboratory animals Matrix protein Medical research Membranes Mesangial cells Mesangial Cells - metabolism Mesangial Cells - pathology Metabolism Mice MicroRNAs MicroRNAs - genetics miR‐296‐3p Nephropathy Original Pathogenesis Proteins Proto-Oncogene Proteins c-akt - genetics RNA Interference RNA, Circular Signal Transduction Statistical analysis Studies |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Na9wwEBVtSqGXkn5vkhaV9tKCGluSZelUypIQAttDaWBvRpblxBDb2_VuSX5H_nBmZK_bJW1utkcI2zPSvBmP3xDy0YNLSHJlGbcmYZIXhuWAdFmcgLviZR7LElMDs-_q5EyezpP5kHDrhrLKzZ4YNuqidZgjP-RSYBEcRAhfF78Ydo3Cr6tDC42H5BFSl2FJVzofAy4BrsoMlKShesfV9ZfQ0WTbCd1BlncLJP8GrsHzHO-SpwNkpN96HT8jD3zznDzum0hevyA302rpGGA1QavmosqrVUcB1VHr3LoemnPRtqSwCy8t5umx8JTWSM1_hddr39nmHMyQorCDSWifkK0cbfwC2ygASrymvytL67YIMzbntK5-MG4UE4vDI-ZsEf4jpFgOAgb9kpwdH_2cnrCh1QJzEnYYVpYxQA2reR4p70UMWiqN0IEuL_W6MBYi2ThVRpUy1kVU-Ij7VFqeWFmaxItXZKdpG_-GUBUV3FhtcwcylRsjdSSdMHDqktS5Cfm0efeZG3jIsR3GZTbGI6CnLOhpQj6MYxc9-8Y_Rx1sVJgNK7DL_tjLf8RKI9m-AfH7UQxLC1-1bXy7xjGxhthD6WhCXvcGMd6FgLAxBfwzIemWqYwDkLZ7W9JUF4G-O8WG3wLm_ByM6p4Hy06ns1k42rv_EffJE455gFCYeEB2Vsu1fwtgaZW_CyviFqUKFZU priority: 102 providerName: ProQuest – databaseName: Wiley Online Library Open Access dbid: 24P link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fi9QwEA_nieCL-N89T4noi0K1TdI0AV9kueM4WBHx4N5KkqZ3BZtdtrty9-ZH8N1v5ydxJu2WW04FX_bfzKbdnZnkN2HyG0JeeVgScitNwozOE8EqnVhAukmWw3LFapuJGrcGZh_l0Yk4Ps1Pd8j7zVmYnh9i3HDDyIjzNQa4sd3VIHdt-zb2J7lBbuLZWmTOZ-LTZh7msFDpyJYKGBIcVw3kpLGOZ_zu9nJ0DWNeL5W8CmHjGnR4l9wZwCP90Fv7Htnx4T651beTvHxAfk6bpfv1_QfgNk6bcN7YZtVRQHjUOLduh0ZddF5TmJGXBvfssQiVtkjTf4Gft74z4QxckqKwg0FovznbOBr8AlsqAGK8pN8aQ9t5FUcMZ7RtPsNlmZbwyBfvDuDJmSqeLKRYIAIu_pCcHB58mR4lQ_OFxAmYc5K6zgB8GMVsKr3nGdit1lxFAr3Cq0obyG2zQmpZi0xVaeVT5gthWG5ErXPPH5HdMA_-CaEyrZg2ylgHMmm1FioVjmt46_LCuQl5vbFB6QZmcmyQ8bUcMxSwVxntNSEvR91Fz8fxR639jSnLISa7kgmOZZSQY_5FLBXS72sQvxjFEGz4h5vg52vUyRRkI1KlE_K4d4zxLjgkkgUgogkptlxmVEAi721JaM4joXeBLcA5jPkmOtc_flh5PJ3N4qu9_1F-Sm4z3CeIhYv7ZHe1XPtnAKZW9nmMmd-bjx-2 priority: 102 providerName: Wiley-Blackwell |
Title | Circ‐AKT3 inhibits the accumulation of extracellular matrix of mesangial cells in diabetic nephropathy via modulating miR‐296‐3p/E‐cadherin signals |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjcmm.15513 https://www.ncbi.nlm.nih.gov/pubmed/32597022 https://www.proquest.com/docview/2430943282 https://www.proquest.com/docview/2468438092 https://www.proquest.com/docview/2418729680 https://pubmed.ncbi.nlm.nih.gov/PMC7412430 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9NAEF71ISQuiHcDJVoEF5Bc7N31Pg4IlShVVSlVVWEUcbHW63VrqXZCHqi58RO48-_4JcyuHYuoBXGxE89648zMer4Zj2cQem3BJMQZ1wHRKg4YyVWQAdINohjMFSmyiBUuNDA65ccJOxnH4y207t_ZMnB-q2vn-kkls6uD66-rD7Dg33dZOaaqDnynkm20CxZJuAU6Yt3TBAomS_m6qYAmQYVlW6Z089xNw3QDbd5MmvwTzHprdHQf3WthJD5s5P4Abdn6IbrTNJZcPUI_B-XM_Pr-AxAcxWV9WWblYo4B62FtzLJqW3bhSYHh3jzTLnrv0lFx5Qr2X7vjlZ3r-gKUEzviHCbBTZi2NLi2U9dcAbDjCn8rNa4muZ-xvsBVeQ4_SxSHLZ2-G8LO6Ny_Y4hdqggw_TFKjoafBsdB24YhMAzuPkFRAEdDLUkWcmtpBBIsFJW-lJ6wMlcavNxIcMULFsk8zG1IrGCaxJoVKrb0CdqpJ7XdQ5iHOVFa6swAjWdKMRkyQxV8NbEwpoferGWQmrZGuWuVcZV2vgrIK_Xy6qFX3dhpU5nj1lH7a1Gma-VKCaMuoRK8zb-QuXSF-BWQX3ZkWHaO4bq2k6UbE0nwS7gMe-hpoxjdVVBwKQVgox4SGyrTDXAlvTcpdXnpS3sL1wycwpxvvXL944-lJ4PRyH969l-MeI7uEhcq8LmL-2hnMVvaF4CnFlkfbRN2BlsxFn20e_g5-ZLA_uPw9Oy872MUfb-cfgOMYCkl |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKVgguiDcLBYyAA0imie048QEhWLbaPnaFqlbqLTiO00YiybIPYH8H_4PfyNh5wKrQW29JxrKSzIznG2cyH0IvDISEIBGKUCUDwmkqSQJIl_gBhCuaJT7P7NbAeCJGx3zvJDjZQL_af2FsWWW7JrqFOq203SPfppzZIjjIEN5NvxLLGmW_rrYUGrVZ7JvVd0jZ5m93P4J-X1K6MzwajEjDKkA0B2ciWeZDVFURTTxhDPPhhjLJItcZLjRRKhUkbX4opMi4H6VeajxqQq5ooHgmA8Ng3itokzNIZXpo88Nw8umwXfsZBEfZNEF19UK6KN44DpX1sHcOy54vyfwbKrtYt3MT3WhAKn5fW9UttGHK2-hqTVu5uoN-DvKZJoAOGc7LszzJF3MMOBIrrZdFQweGqwzDuj9T9suALXXFhSUD-GGvF2auylMwfGyFc5gE11vAucalmVriBsClK_wtV7ioUjdjeYqL_JBQKQibbg-JVqn7cxHbAhRwobvo-FLUcA_1yqo0DxAWXkqlilSiQSYSKXnkcc0knOog1LqPXrXvPtZN53NLwPEl7jIg0FPs9NRHz7ux07rfxz9HbbUqjBufn8d_LPQ_YhHZ9v4SxM86MTizfdWqNNXSjvEjyHZE5PXR_dogurtgkKiGgLj6KFwzlW6AbRS-LinzM9cwPLQU4wzmfO2M6oIHi_cG47E7enjxIz5F10ZH44P4YHey_whdp3YXwpVFbqHeYrY0jwGqLZInjX9g9PmyXfI3Q39SMA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYhLxZstBYyAA0hmEzsvHxBC2676YCuEqLS34DhOG4kky2YX2N_Bv-HXMeM8YFXorbckY1mJZybzjTOZj5DnBkKCnwSKcSV95vFUsgSQLnN9CFc8S1wvw62ByXGwf-IdTv3pBvnV_QuDZZXdO9G-qNNK4x75kHsCi-AgQxhmbVnEh93x29lXhgxS-KW1o9NoTOTIrL5D-la_OdgFXb_gfLz3abTPWoYBpj1wLJZlLkRYFfHECYwRLtxcJkVku8SFJkqlggTODQMZZJ4bpU5qHG5CT3FfeZn0jYB5r5CrofBd9LFw2id7AsKkbNuh2sohXRSvLZvKegA8h2rPF2f-DZpt1BvfJFstXKXvGvu6RTZMeZtcawgsV3fIz1E-1wxwoqB5eZYn-aKmgCip0npZtMRgtMooLONc4TcCLHqlBdIC_MDrhalVeQouQFFYwyS02QzONS3NDCkcAKGu6Ldc0aJK7YzlKS3yj4zLgInZcI9pldp_GCmWooAz3SUnl6KEe2SzrErzgNDASblUkUo0yIJESi9yPC0knGo_1HpAXnZrH-u2BzpScXyJ-1wI9BRbPQ3Is37srOn88c9RO50K49b76_iPrf5HHETY6F-C-GkvBrfGpValqZY4xo0g7wkiZ0DuNwbR34WAlDUE7DUg4Zqp9AOwZfi6pMzPbOvwEMnGBcz5yhrVBQ8WH44mE3u0ffEjPiHXwRHj9wfHRw_JDY7bEbY-codsLuZL8wgw2yJ5bJ2Dks-X7Y2_ASq4VQA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Circ%E2%80%90AKT3+inhibits+the+accumulation+of+extracellular+matrix+of+mesangial+cells+in+diabetic+nephropathy+via+modulating+miR%E2%80%90296%E2%80%903p%2FE%E2%80%90cadherin+signals&rft.jtitle=Journal+of+cellular+and+molecular+medicine&rft.au=Tang%2C+Bo&rft.au=Li%2C+Weiliang&rft.au=Ji%2C+Ting%E2%80%90Ting&rft.au=Li%2C+Xiao%E2%80%90Ying&rft.date=2020-08-01&rft.issn=1582-1838&rft.eissn=1582-4934&rft.volume=24&rft.issue=15&rft.spage=8779&rft.epage=8788&rft_id=info:doi/10.1111%2Fjcmm.15513&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_jcmm_15513 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1582-1838&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1582-1838&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1582-1838&client=summon |